Antipsychotic Drugs
Publication Date
February 2024
USD 9.65 billion
USD 16.56 billion
USD 10.42 billion
Antipsychotic Drugs Market by Class (First Generation, Second Generation, Third Generation), Indication (Bipolar Disorders, Dementia, Schizophrenia) - Global Forecast 2024-2030

[198 Pages Report] The Antipsychotic Drugs Market size was estimated at USD 9.65 billion in 2023 and expected to reach USD 10.42 billion in 2024, at a CAGR 8.01% to reach USD 16.56 billion by 2030.

Antipsychotic Drugs Market
To learn more about this report, request a free sample copy
Antipsychotic Drugs Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antipsychotic Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antipsychotic Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antipsychotic Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alkermes, Inc., AMBOSS GmbH, Amgen Inc, Arlak Biotech, AstraZeneca PLC, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, Dr. Reddy's Laboratories, Ltd., Eli Lilly and Company, Flagship Biotech International Pvt. Ltd., GlaxoSmithKline PLC, H. Lundbeck A/S, Johnson & Johnson Services Inc., Lifecare Neuro Products Ltd., Luye Pharma Group, Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer, Inc., S. Karger AG, Seqirus Pty Ltd, Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries, Ltd., and Vanda Pharmaceuticals Inc..

Market Segmentation & Coverage

This research report categorizes the Antipsychotic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Class
    • First Generation
      • Haldo
      • Navane
    • Second Generation
      • Geodon
      • Invega
      • Latuda
      • Risperdal
      • Seroquel
      • Zyprexa
    • Third Generation
      • Abilify
  • Indication
    • Bipolar Disorders
    • Dementia
    • Schizophrenia
    • Unipolar Depression

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Antipsychotic Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antipsychotic Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Antipsychotic Drugs Market?
  4. What is the market share of the leading vendors in the Antipsychotic Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Antipsychotic Drugs Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Antipsychotic Drugs Market, by Class
  7. Antipsychotic Drugs Market, by Indication
  8. Americas Antipsychotic Drugs Market
  9. Asia-Pacific Antipsychotic Drugs Market
  10. Europe, Middle East & Africa Antipsychotic Drugs Market
  11. Competitive Landscape
  12. Competitive Portfolio
Companies Mentioned
  • AbbVie Inc.
  • Alkermes, Inc.
  • Amgen Inc
  • Arlak Biotech
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company, Limited
  • Dr. Reddy's Laboratories, Ltd.
  • Eli Lilly and Company
  • Flagship Biotech International Pvt. Ltd.
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Johnson & Johnson Services Inc.
  • Lifecare Neuro Products Ltd.
  • Luye Pharma Group
  • Merck & Co., Inc.
  • Novartis AG
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer, Inc.
  • S. Karger AG
  • Seqirus Pty Ltd
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Teva Pharmaceutical Industries, Ltd.
  • Vanda Pharmaceuticals Inc.
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Antipsychotic Drugs Market
The Global Antipsychotic Drugs Market size was estimated at USD 9.65 billion in 2023 and expected to reach USD 10.42 billion in 2024.
The Global Antipsychotic Drugs Market to grow USD 16.56 billion by 2030, at a CAGR of 8.01%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.